Literature DB >> 31476920

Low Educational Attainment is a Predictor of Adverse Outcomes in Patients With Coronary Artery Disease.

Heval M Kelli1, Anurag Mehta1, Ayman S Tahhan1, Chang Liu1,2, Jeong Hwan Kim1, Tiffany A Dong1,3, Devinder S Dhindsa1, Bahjat Ghazzal1, Muaaz K Choudhary1, Pratik B Sandesara1, Salim S Hayek4, Matthew L Topel1, Ayman A Alkhoder1, Mohamed A Martini1, Arianna Sidoti1, Yi-An Ko1,2, Tene T Lewis2, Viola Vaccarino1, Laurence S Sperling1, Arshed A Quyyumi1.   

Abstract

Background Educational attainment is an indicator of socioeconomic status and is inversely associated with coronary artery disease risk. Whether educational attainment level (EAL) among patients with coronary artery disease influences outcomes remains understudied. Methods and Results Patients undergoing cardiac catheterization had their highest EAL assessed using options of elementary/middle school, high school, college, or graduate education. Primary outcome was all-cause mortality and secondary outcomes were a composite of cardiovascular death/non-fatal myocardial infarction and non-fatal myocardial infarction during follow-up. Cox models adjusted for clinically relevant confounders were used to analyze the association of EAL with outcomes. Among 6318 patients (63.5 years, 63% men, 23% black) enrolled, 16%, 42%, 38%, and 4% had received graduate or higher, college, high school, and elementary/middle school education, respectively. During 4.2 median years of follow-up, there were 1066 all-cause deaths, 812 cardiovascular deaths/non-fatal myocardial infarction, and 276 non-fatal myocardial infarction. Compared with patients with graduate education, those in lower EAL categories (elementary/middle school, high school, or college education) had a higher risk of all-cause mortality (hazard ratios 1.52 [95% CI 1.11-2.09]; 1.43 [95% CI 1.17-1.73]; and 95% CI 1.26 [1.03-1.53], respectively). Similar findings were observed for secondary outcomes. Conclusions Low educational attainment is an independent predictor of adverse outcomes in patients undergoing angiographic coronary artery disease evaluation. The utility of incorporating EAL into risk assessment algorithms and the causal link between low EAL and adverse outcomes in this high-risk patient population need further investigation.

Entities:  

Keywords:  cardiovascular outcomes; education; risk assessment; secondary prevention; socioeconomic position

Mesh:

Year:  2019        PMID: 31476920      PMCID: PMC6755831          DOI: 10.1161/JAHA.119.013165

Source DB:  PubMed          Journal:  J Am Heart Assoc        ISSN: 2047-9980            Impact factor:   5.501


Clinical Perspective

What Is New?

Low educational attainment is directly associated with coronary artery disease risk in the general population, but the association of educational attainment level with adverse outcomes in patients with coronary artery disease is unclear. Our study demonstrates that educational attainment below graduate level is associated with an increased risk of mortality and cardiovascular events among patients undergoing coronary angiography for evaluation of coronary artery disease.

What Are the Clinical Implications?

Patients with coronary artery disease and low educational attainment are a high‐risk population. Routine assessment of educational attainment level may help target management resources towards those with low educational attainment, which in turn may help improve outcomes.

Introduction

Cardiovascular disease (CVD) is the leading cause of mortality across the world and in the United States.1 Although traditional cardiovascular risk factors such as hypertension, hyperlipidemia, diabetes mellitus, and smoking are associated with atherosclerotic CVD, these factors do not fully account for the observed rates of adverse outcomes in patients with established CVD.2 Social determinants of health, exemplified by neighborhood socioeconomic factors and individual socioeconomic status (SES) determined by income, occupation, and educational attainment level (EAL), contribute to the risk of adverse cardiovascular events in the general population.3 It is well‐established that SES has a strong inverse association with cardiovascular risk factors and risk of incident CVD in high‐income countries.4 A common indicator of SES is educational attainment, which by itself has an inverse dose‐response relationship with the lifetime risk of incident CVD among asymptomatic individuals.5 A recent mendelian randomization study has additionally established that genetic predisposition to higher educational attainment is associated with a decreased risk of coronary heart disease.6 The association between EAL and coronary artery disease (CAD) incidence is often thought to be mediated through modifiable lifestyle‐related cardiovascular risk factors, but the exact causal link between low EAL and elevated cardiovascular risk is not completely understood.7 Furthermore, there is a paucity of literature evaluating the association between EAL and adverse outcomes among patients with established CAD. It is plausible that similar to the association between low EAL and incident CVD among asymptomatic individuals, low educational attainment portends a worse outcome among patients with CAD. In this study, we sought to investigate the independent association of EAL with adverse cardiovascular outcomes among patients with suspected or known CAD and hypothesized that low educational attainment is an independent predictor of adverse outcomes in this high‐risk patient population.

Methods

Study Population

The patients analyzed in this study are participants of the Emory Cardiovascular Biobank. Briefly, the Biobank is an ongoing prospective registry of adult patients undergoing cardiac catheterization for suspected or confirmed CAD at 3 Emory Healthcare affiliated hospitals in Atlanta, Georgia.8 In the current study we included patients that were enrolled between the years 2003 and 2015. Patients with heart transplantation, severe valvular heart disease, and active cancer were excluded. The data that support the findings of this study are available from the corresponding author upon reasonable request.

Educational Attainment Level

On a questionnaire, patients selected predefined options for their highest level of educational attainment that included: (1) elementary or middle school education, (2) high school education, (3) college education, and (4) graduate education or higher. A total of 6318 eligible patients had information available on EAL and were included in the current analysis.

Cardiovascular Risk Factors

Patients were interviewed to collect information about demographic characteristics, medical history, medication use, and behavioral habits as previously described.8 The prevalence of hypertension, hyperlipidemia, diabetes mellitus, prior myocardial infarction (MI), and established CAD was determined by physician diagnosis and/or treatment.8 Medical records and International Classification of Diseases‐Ninth Revision (ICD‐9) diagnostic codes were reviewed to confirm self‐reported medical history. Weight and height were measured at enrollment and body mass index was calculated by dividing weight (in kilogram) by height (in meters)‐square. Left ventricular ejection fraction was abstracted after reviewing medical records and estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration equation.9 Angiographic scoring was performed using the Gensini score that quantifies CAD severity by a non‐linear points system for degree of luminal narrowing and has been shown to have prognostic significance.10 Epicardial coronary luminal narrowing <10% was designated as normal vasculature during coronary angiography.8 The presence of an acute coronary syndrome and revascularization of any coronary artery at time of enrollment was also recorded. Overall, 0% to 9.5% participants had data missing for ≥1 of the covariates listed above (details in Data S1) and this data were assumed to be missing at random. Individual household income was not collected in this study and the median annual household income based on patientszip code estimated using US census data is reported.11 This study was approved by the institutional review board at Emory University (Atlanta, Georgia) and all patients provided written informed consent at the time of enrollment.

Adverse Outcomes

Study participants were prospectively followed for the primary outcome of interest, all‐cause mortality, as well as 2 secondary outcomes—a composite of cardiovascular death and non‐fatal MI, and non‐fatal MI events alone. Follow‐up data were obtained by annual phone contact, electronic medical record review, and data from the social security death index and state records.8 The cause of death was determined from medical record review or by direct contact with the participants’ family member(s). Non‐fatal MI events and cardiovascular death were adjudicated by 2 cardiologists who were blinded to study data. Non‐fatal MI events were adjudicated using the third universal definition of MI,12 and cardiovascular death was defined as death attributable to an ischemic cardiovascular cause like fatal MI, stroke or sudden death secondary to a presumed cardiovascular cause in this high‐risk population.13 Follow‐up data for primary and secondary outcomes were available for 5962 (94.4%) of the patients and we performed a landmark analysis wherein the association of EAL with outcomes was ascertained among 5825 patients who did not experience the primary outcome within 30 days of enrollment.

Statistical Analysis

Participant characteristics were reported as frequencies for categorical variables and means (standard deviation) or medians [25th–75th percentile] for continuous variables depending on distribution. Differences between EAL groups were assessed using the analysis of variance test for normally distributed continuous variables and the Chi‐square test for categorical variables where appropriate. The Kruskal–Wallis test was used to compare non‐normally distributed variables among groups. Unadjusted Cox proportional hazards regression models were used to identify patient characteristics associated with the primary outcome. Kaplan–Meier survival curves and multivariable‐adjusted Cox models were used to examine the association between EAL and all‐cause mortality, composite of cardiovascular death/non‐fatal MI, and non‐fatal MI events. Cox models were adjusted for age, sex, race, smoking, diabetes mellitus, hypertension, hyperlipidemia, history of CAD, body mass index, left ventricular ejection fraction, eGFR, Gensini score, cardiovascular medication (aspirin, statin, beta blocker, and angiotensin‐converting enzyme inhibitor or angiotensin‐II receptor blocker [ARB]) use, as well as acute coronary syndrome and coronary revascularization at enrollment. We intentionally adjusted for several CVD risk factors because of the known baseline differences in risk factor burden between patients with different EAL in our cohort.11 Missing data for covariates used in the adjusted Cox models were imputed using the Visualization and Imputation of Missing values R package by using the k‐nearest neighbors approach.14 Additionally, the effect of unmeasured confounders on these associations was estimated by computing E‐values.15 We further adjusted Cox models for zip‐code based estimated annual income as a sensitivity analysis. We also evaluated the association of EAL with outcomes after excluding patients with normal epicardial coronary arteries on angiography (<10% angiographic stenosis) in a separate model. The multiplicative interaction of several clinical covariates (age [dichotomized at 65 years], sex, race, diabetes mellitus, hypertension, smoking, hyperlipidemia, eGFR [dichotomized at 60 mL/min per 1.73 m2], BMI [dichotomized at 30 kg/m2], history of CAD, acute coronary syndrome at enrollment, and coronary revascularization at enrollment) with EAL dichotomized at graduate education for predicting all‐cause mortality was tested in adjusted Cox models as well. Lastly, we classified patients into 4 mutually exclusive groups based on EAL dichotomized at college education and history of prior MI to study the joint association of EAL and prior MI with the primary outcome using Kaplan–Meier survival curves. All analyses were performed using IBM SPSS Statistics Version 25 (Armonk, NY) and R version 3.3.3 (R Foundation for statistical computing, Vienna, Austria). Two‐tailed P<0.05 were considered statistically significant. The STROBE statement for this observational cohort study is provided in Table S1.

Results

Patient Characteristics

Baseline demographic and clinical characteristics of study patients stratified by EAL are presented in Table 1. The study cohort was 63% men, 23% black, with a mean age of 63.5 years. The highest EAL was graduate or higher level of education and was observed in 16% patients, while 42% obtained college education, 38% had a high school diploma, and 4% had an elementary or middle school education (Table 1). Patients with lower EAL were older, more frequently women, black, and had a higher prevalence of smoking, diabetes mellitus, hypertension, history of CAD, and had a higher Gensini score along with a lower left ventricular ejection fraction, eGFR, and estimated annual income as compared with patients with higher EAL (Table 1). Normal coronary arteries were observed in 11% of the study cohort and EAL has an inverse association with its prevalence (Table 1).
Table 1

Baseline Characteristics of Participants Stratified by Level of Educational Attainment

Participant CharacteristicsAll Patients (n=6318)Elementary/Middle School Education (n=228)High School Education (n=2403)College Education (n=2689)Graduate Education (n=998) P Value
Age, y63.5 (12.2)67.4 (12.0)63.6 (12.0)62.9 (12.3)64.2 (12.0)<0.001
Men3995 (63.2)135 (59.2)1402 (58.3)1719 (63.9)739 (74.0)<0.001
Black race1470 (23.3)62 (27.2)604 (25.1)620 (23.1)184 (18.4)<0.001
Ever smoking4071 (64.4)162 (71.1)1649 (68.6)1664 (61.9)596 (59.7)<0.001
Diabetes mellitus2193 (34.9)99 (43.4)895 (37.5)887 (33.2)312 (31.3)<0.001
Hypertension4945 (78.6)188 (83.2)1932 (80.7)2096 (78.3)729 (73.3)<0.001
Hyperlipidemia4476 (71.2)168 (74.3)1707 (71.3)1905 (71.1)696 (70.1)0.637
History of myocardial infarction1463 (23.4)75 (33.2)602 (25.3)587 (22.1)199 (20.3)<0.001
History of coronary artery disease4774 (75.6)190 (83.3)1851 (77.0)1983 (73.7)750 (75.2)0.002
Body mass index, kg/m2 29.8 (6.8)29.5 (6.5)29.9 (6.5)30.1 (7.23)29.2 (6.1)0.010
Left ventricular ejection fraction (%)52.8 (12.8)50.6 (13.5)55.0 (13.1)53.2 (12.7)52.9 (12.3)0.015
eGFR, mL/min per 1.73 m2 73.0 (24.4)69.5 (23.9)72.1 (249)74.0 (24.3)73.6 (23.4)0.005
ACS at enrollment1165 (18.4)49 (21.5)454 (18.9)478 (17.8)184 (18.4)0.470
Normal coronaries on angiogram698 (11.0)12 (5.3)246 (10.2)314 (12.7)126 (12.6)0.005
Gensini score7.5 [0.0–35.5]8.3 [0.0–29.9]8.0 [0.0–37.5]6.0 [0.0–33.5]8.0 [0.0–39.0]0.035
Revascularization at enrollment2210 (35.0)84 (36.8)865 (36.0)927 (34.5)334 (33.5)0.432
Estimated annual income (US dollars)46 646 [37 109–60 428]40 982 [35 433–50 983]42 902 [36 465–53 818]48 210 [38 852–63 338]52 167 [40 982–67 335]<0.001
Aspirin use4727 (74.8)173 (75.9)1781 (74.1)1988 (73.9)785 (78.7)0.021
Statin use4407 (69.8)169 (74.1)1637 (68.1)1854 (68.9)747 (74.8)<0.001
Beta blocker use4207 (66.6)161 (70.6)1641 (68.3)1718 (63.9)687 (68.8)0.001
ACE inhibitor/ARB use3457 (54.7)137 (60.1)1314 (54.7)1458 (54.2)548 (54.9)0.401

Values shown are number (percentage) and mean (standard deviation) for normally distributed variables or median [25th–75th percentile] for non‐normally distributed variables. ACE indicates angiotensin‐converting enzyme; ACS, acute coronary syndrome; ARB, angiotensin II receptor blocker; eGFR, estimated glomerular filtration rate; MI, myocardial infarction.

Baseline Characteristics of Participants Stratified by Level of Educational Attainment Values shown are number (percentage) and mean (standard deviation) for normally distributed variables or median [25th–75th percentile] for non‐normally distributed variables. ACE indicates angiotensin‐converting enzyme; ACS, acute coronary syndrome; ARB, angiotensin II receptor blocker; eGFR, estimated glomerular filtration rate; MI, myocardial infarction.

Adverse Cardiovascular Outcomes

Patients who did not experience the primary outcome within 30 days of enrollment and had adjudicated outcomes data available for analysis were followed for a median duration of 4.2 [1.8–6.8] years. There were 1066 all‐cause deaths, 812 cardiovascular deaths/non‐fatal MI and 276 non‐fatal MI events. Older age, smoking, diabetes mellitus, hypertension, history of CAD, and Gensini score were directly associated; while BMI, left ventricular ejection fraction, eGFR, and estimated annual income were inversely associated with all‐cause mortality in study patients (Table S2).

Educational Attainment Level and Adverse Outcomes

Kaplan–Meier survival curves for the association between EAL and all‐cause mortality are shown in Figure 1 (Central Illustration). The cumulative survival for study participants decreased across categories of graduate, college, high school, and elementary/middle school education. A similar trend was observed for the secondary outcomes of cardiovascular death/non‐fatal MI and non‐fatal MI events (Figure 2A and 2B). In unadjusted Cox proportional hazards regression analyses, patients with elementary/middle school, high school, or college education had a 104%, 57%, and 24% higher risk of all‐cause mortality compared with those with graduate education, respectively. Similarly, there was a significantly higher hazard for the secondary outcomes of cardiovascular death/non‐fatal MI and non‐fatal MI among those with elementary/middle school and high school education compared with graduate education level (Table 2).
Figure 1

Association between level of educational attainment and all‐cause mortality. Kaplan–Meier curves for categories of graduate, college, high school, and elementary/middle school education. The cumulative survival of study participants progressively decreased across categories of educational attainment level, with the highest all‐cause mortality risk observed among those with elementary/middle school education.

Figure 2

Association of level of educational attainment with composite of cardiovascular death/non‐f school education. The cumulative survival of study participants from cardiovascular death/non‐fatal myocardial infarction and non‐fatal myocardial infarction progressively decreased across categories of educational attainment level with the highest risk observed among those with elementary/middle school education.

Table 2

Association Between Level of Educational Attainment and Adverse Outcomes

Educational LevelAll‐Cause MortalityCardiovascular Death/Nonfatal MINonfatal MI
HR (95% CI) P ValueHR (95% CI) P ValueHR (95% CI) P Value
UnadjustedElementary/Middle school2.04 (1.49–2.79)<0.0012.01 (1.40–2.90)<0.0012.40 (1.32–4.37)0.004
High school1.57 (1.29–1.90)<0.0011.56 (1.25–1.95)<0.0011.69 (1.15–2.50)0.004
College1.24 (1.02–1.51)0.0321.24 (0.99–1.55)0.0621.27 (0.86–1.89)0.235
GraduateReferentReferentReferent
Adjusteda Elementary/Middle school1.52 (1.11–2.09)0.0101.46 (1.02–2.11)0.0411.84 (1.01–3.38)0.048
High school1.43 (1.17–1.73)<0.0011.38 (1.10–1.73)0.0051.49 (1.004–2.20)0.048
College1.26 (1.03–1.53)0.0231.24 (0.99–1.56)0.0601.25 (0.84–1.86)0.273
GraduateReferentReferentReferent

Survival analysis for 5825 participants—218 elementary/middle school education (55 all‐cause deaths, 41 cardiovascular death/non‐fatal MI, and 16 non‐fatal MI), 2213 high school education (463 all‐cause deaths, 352 cardiovascular death/non‐fatal MI, and 123 non‐fatal MI), 2469 college education (415 all‐cause deaths, 318 cardiovascular death/non‐fatal MI, and 105 non‐fatal MI), and 925 graduate education (133 all‐cause deaths, 101 cardiovascular death/non‐fatal MI, and 32 non‐fatal MI). HR indicates hazard ratio; MI, myocardial infarction.

Model adjusted for age, sex, race, ever smoking, diabetes mellitus, hypertension, hyperlipidemia, history of coronary artery disease, body mass index, left ventricular ejection fraction, estimated glomerular filtration rate, Gensini score, cardiovascular medication (aspirin, statin, beta blocker, and ACE inhibitor/ARB) use, acute coronary syndrome and coronary revascularization at enrollment.

Association between level of educational attainment and all‐cause mortality. Kaplan–Meier curves for categories of graduate, college, high school, and elementary/middle school education. The cumulative survival of study participants progressively decreased across categories of educational attainment level, with the highest all‐cause mortality risk observed among those with elementary/middle school education. Association of level of educational attainment with composite of cardiovascular death/non‐f school education. The cumulative survival of study participants from cardiovascular death/non‐fatal myocardial infarction and non‐fatal myocardial infarction progressively decreased across categories of educational attainment level with the highest risk observed among those with elementary/middle school education. Association Between Level of Educational Attainment and Adverse Outcomes Survival analysis for 5825 participants—218 elementary/middle school education (55 all‐cause deaths, 41 cardiovascular death/non‐fatal MI, and 16 non‐fatal MI), 2213 high school education (463 all‐cause deaths, 352 cardiovascular death/non‐fatal MI, and 123 non‐fatal MI), 2469 college education (415 all‐cause deaths, 318 cardiovascular death/non‐fatal MI, and 105 non‐fatal MI), and 925 graduate education (133 all‐cause deaths, 101 cardiovascular death/non‐fatal MI, and 32 non‐fatal MI). HR indicates hazard ratio; MI, myocardial infarction. Model adjusted for age, sex, race, ever smoking, diabetes mellitus, hypertension, hyperlipidemia, history of coronary artery disease, body mass index, left ventricular ejection fraction, estimated glomerular filtration rate, Gensini score, cardiovascular medication (aspirin, statin, beta blocker, and ACE inhibitor/ARB) use, acute coronary syndrome and coronary revascularization at enrollment. After adjustment for demographic characteristics, risk factors, angiographic CAD severity, cardiovascular medications, and revascularization at enrollment the inverse association between EAL and all‐cause mortality remained statistically significant (Table 2). Thus, compared with patients with graduate education, those with elementary/middle school, high school, or college education had a 52%, 43%, and 26% increased risk of all‐cause mortality, respectively (Table 2). Sensitivity analyses for this observation were performed by computing the E‐value and these results are reported in Data S1. The significant unadjusted associations between EAL categories of elementary/middle school and high school education and the secondary outcomes remained significant after multivariate adjustment as well (Table 2).

Sensitivity Analyses

The independent association between EAL categories and all‐cause mortality was not attenuated after Cox models were further adjusted for estimated annual income (Table S3). Furthermore, after excluding participants with normal coronary arteries the association of elementary/middle school and high school education with the primary and secondary outcomes remained significant (Table S4). EAL dichotomized at graduate education was also independently associated with all‐cause mortality (hazard ratio 1.31, 95% CI 1.09–1.57). We found no significant heterogeneity in this relationship based on age, race, diabetes mellitus, hypertension, smoking, hyperlipidemia, BMI, history of CAD, ACS at enrollment, and revascularization at enrollment (Figure 3). However, the association of EAL and all‐cause mortality was significantly modified by sex (P‐interaction=0.044) and by renal function impairment (eGFR <60 mL/min per 1.73 m2, P‐interaction=0.044), such that the strength of this association was stronger among women and among patients with preserved renal function as compared with men and those with renal function impairment, respectively (Figure 3).
Figure 3

Interaction between educational attainment level dichotomized at graduate education and clinical characteristics for risk of all‐cause mortality. Cox proportional hazards regression model to ascertain the association between educational attainment level dichotomized at graduate education and all‐cause mortality. Model adjusted for age (dichotomized at 65 years), sex, race, diabetes mellitus, hypertension, ever smoking, hyperlipidemia, eGFR (dichotomized at 60 mL/min per 1.73 m2), body mass index (dichotomized at 30 kg/m2), left ventricular ejection fraction, history of coronary artery disease, Gensini score, cardiovascular medication (aspirin, statin, beta blocker, and angiotensin‐converting enzyme inhibitor or angiotensin‐II receptor blocker) use, acute coronary syndrome at enrollment, and coronary revascularization at enrollment. The relationship was significantly modified by sex and by renal function, such that the association was attenuated among men and participants with renal function impairment. ACS indicates acute coronary syndrome; BMI, body mass index; CAD, coronary artery disease; eGFR, estimated glomerular filtration rate.

Interaction between educational attainment level dichotomized at graduate education and clinical characteristics for risk of all‐cause mortality. Cox proportional hazards regression model to ascertain the association between educational attainment level dichotomized at graduate education and all‐cause mortality. Model adjusted for age (dichotomized at 65 years), sex, race, diabetes mellitus, hypertension, ever smoking, hyperlipidemia, eGFR (dichotomized at 60 mL/min per 1.73 m2), body mass index (dichotomized at 30 kg/m2), left ventricular ejection fraction, history of coronary artery disease, Gensini score, cardiovascular medication (aspirin, statin, beta blocker, and angiotensin‐converting enzyme inhibitor or angiotensin‐II receptor blocker) use, acute coronary syndrome at enrollment, and coronary revascularization at enrollment. The relationship was significantly modified by sex and by renal function, such that the association was attenuated among men and participants with renal function impairment. ACS indicates acute coronary syndrome; BMI, body mass index; CAD, coronary artery disease; eGFR, estimated glomerular filtration rate. Lastly, we classified study participants into 4 mutually exclusive groups based on EAL dichotomized at college education and history of prior MI. Among patients with EAL below college education, 26% had a history of prior MI and the corresponding proportion among those with EAL above college education was 22%. Patients without college education and prior history of MI had the highest risk for all‐cause mortality during follow‐up. Notably, all‐cause mortality incidence among patients with college education and prior MI was similar to patients with a lack of college education and without prior MI (Figure S1).

Discussion

In this large cohort study of patients undergoing cardiac catheterization for evaluation of CAD we report several important findings. First, we demonstrated that lower EAL predicts adverse cardiovascular outcomes and this inverse association was persistent and graded throughout various levels of educational attainment from elementary/middle school, high school, college, to graduate education; with the highest adjusted risk observed in those with the lowest EAL. Second, the impact of EAL on the primary outcome of all‐cause mortality was independent of estimated annual income which is another marker of SES. Third, EAL below graduate education was independently associated with all‐cause mortality and the strength of this association was higher among women and those without renal function impairment. Lastly, the impact of having an EAL below college education was similar to having a history of prior MI, such that the all‐cause mortality incidence was similar in patients who were college educated and had a prior MI as those who were not college educated but had no history of MI. Level of educational attainment is known to be associated with traditional cardiovascular risk factors among asymptomatic individuals living in heterogeneous socioeconomic conditions.16 Indeed, it has been shown that nearly half of the CVD risk conferred by low educational attainment is mediated by behavioral and biological risk factors.17 Herein, we confirmed this increased prevalence of cardiovascular risk factors in our cohort of patients undergoing evaluation of CAD. Our results indicate that there is a graded decline in prevalent cardiovascular risk factors including smoking, hypertension, and diabetes mellitus across the spectrum of increasing EAL. Moreover, we found that the prevalence of established CAD and CAD severity was higher among patients with low EAL. Previous studies in the general population without known CVD have also revealed an inverse relationship between educational attainment and risk of adverse cardiovascular outcomes.18, 19, 20, 21 A meta‐analysis by Manrique‐Garcia et al showed that lower educational attainment was associated with a pooled 34% increased risk of developing an acute MI.20 In an updated meta‐analysis, Khaing et al reported that low EAL was associated with a 23% to 39% increased risk of stroke, CAD, and cardiovascular death.21 Our study is unique in that it is the first to show an inverse relationship between EAL and adverse outcomes in a large cohort of patients undergoing invasive evaluation of CAD even after demographic characteristics, cardiovascular risk factors, angiographic CAD severity, cardiovascular medications, and coronary revascularization are accounted for. The increased strength of association between EAL below graduate education and mortality among women merits attention. Low educational attainment is known to be an independent predictor for fatal CVD events among women with established CVD.22 However, no study to date has explored the sex‐based differential impact of EAL on survival among patients with suspected or confirmed CAD. Our data suggest that the survival benefit afforded by higher EAL among these patients is heightened among women as compared with men. The reasons for this observation are unclear and it is possible that women with low EAL are more prone to having sub‐optimal preventive lifestyle behaviors, medication non‐adherence, mental stress, depression, and poor access to care as compared with men. We additionally observed that the EAL below graduate education and all‐cause mortality association was modified by renal function with a stronger association seen among patients without renal function impairment. Chronic kidney disease (eGFR below 60 mL/min per 1.73 m2) has been recognized as a “high‐risk condition” among patients with established CVD in the current American cholesterol management guidelines.23 Our data show that EAL below graduate education retains its independent predictive value among patients that do not harbor this high‐risk condition. It is also well‐established that household income and EAL are 2 core components of SES and a previous study from the Stanford 5‐city project revealed that these measures are correlated, but EAL had a stronger association with traditional cardiovascular risk factors like smoking, blood pressure, and serum cholesterol.18 A more recent analysis from the Reasons for Geographic And Racial Differences in Stroke (REGARDS) study showed that both low household income and EAL have an additive joint association for predicting CVD risk among asymptomatic individuals.24 Notably, in the meta‐analysis by Khaing and colleagues the effect size of the pooled estimate of the association of low income and low EAL with adverse outcomes was similar.21 Herein, we did not collect information about individual household income and leveraged information from patientszip‐code of residence to obtain estimated median annual income for the patients’ neighborhood. Importantly, we observed that the association between EAL and the primary outcome was not attenuated after adjusting for estimated income. The mechanisms underlying the association between educational attainment and cardiovascular outcomes are likely multifactorial and involve a complex interplay of poor health literacy exacerbating unhealthy lifestyle habits and medication non‐compliance.16 Without the necessary education to motivate change, unhealthy behaviors are more likely to persist, increasing the risk of CVD among poorly educated individuals compared with their more educated counterparts. Thus, even after undergoing cardiac catheterization, patients with low EAL may not realize that continuing behavioral habits like smoking puts them at a higher risk for future events. This was evident in our cohort where a significantly higher proportion of patients with elementary/middle school education were smokers as compared with patients with graduate education. Patients with lower EAL are also likely to have poorer access to healthcare and such disparity is likely driven by multiple factors including financial barriers. These patients are more likely to present with advanced stages of chronic medical conditions compared with patients with more years of schooling. Herein, we show that even within those with suspected or confirmed CAD and high burden of traditional risk factors, low EAL independently identifies those with even higher risk of future adverse events.

Strengths

Our study has several strengths. We have evaluated the association between EAL and cardiovascular outcomes in a region of the United States where there is significant racial and regional disparity in the incidence of CVD. Unlike a number of previously published population‐based studies of asymptomatic individuals our study investigated a population with a high prevalence of established CAD. Our study sample is large and with nearly 1100 deaths recorded during follow‐up we are adequately powered to study the impact of EAL on adverse outcomes in a high‐risk patient population.

Limitations

This study should be interpreted in the context of its limitations. We report findings from a single center study of an urban, high‐risk southeastern US patient population and our cohort's EAL is significantly higher than the national average as reported by the U.S. Census Bureau,25 which limits the generalizability of our findings. Our study participants were referred for cardiac catheterization and might have received more intensive follow‐up after the procedure, however, this is likely to have been similar in all EAL subsets. Despite this possibility, we were found an independent association between EAL and adverse outcomes in our cohort. The association of EAL with outcomes was assessed after controlling for prevalent cardiovascular risk factors, but the time duration of harboring these risk factors as well as change in risk factor levels and preventive medications over time has not been accounted for. Also, we did not gather data on individual household income and insurance status which could influence access to healthcare in this population and in turn affect patient outcomes. Lastly, although we have adjusted for multiple confounders and performed several sensitivity analyses, the possibility of residual confounding cannot be completely excluded given the observational nature of this study.

Conclusions

In patients undergoing cardiac catheterization for evaluation of CAD, EAL was independently associated with adverse outcomes both in overall mortality and cardiovascular events. Routine assessment of EAL among such patients may help guide management decisions and targeting of specific resources towards those with low EAL to improve outcomes. Additional studies are warranted to evaluate the impact of incorporating EAL into risk assessment algorithms for patients with CAD and to clarify the causative link between low education level and adverse cardiovascular outcomes.

Sources of Funding

Kelli, Mehta, Tahhan, Kim, Dhindsa, and Sandesara have been supported by the Abraham J. and Phyllis Katz Foundation. Kelli has been supported by NHLBI T32 THL130025A grant. Mehta is supported by American Heart Association grant 19POST34400057. Quyyumi is supported by NIH grants 1R61HL138657‐02, 1P30DK111024‐03S1, 5R01HL095479‐08, 3RF1AG051633‐01S2, 5R01AG042127‐06, 2P01HL086773‐08, U54AG062334‐01, 1R01HL141205‐01, 5P01HL101398‐02, 1P20HL113451‐01, 5P01HL086773‐09, 1RF1AG051633‐01, R01 NS064162‐01, R01 HL89650‐01, HL095479‐01, 1DP3DK094346‐01, 2P01HL086773, and American Heart Association grant 15SFCRN23910003.

Disclosures

None. Data S1. Table S1. STROBE Statement—Checklist of Items That Should be Included in Reports of Cohort Studies Table S2. Association of Clinical Characteristics With All‐Cause Mortality Table S3. Association Between Level of Educational Attainment and Adverse Outcomes After Adjusting for Estimated Annual Income Table S4. Association Between Level of Educational Attainment and Adverse Outcomes After Excluding Patients With Normal Epicardial Coronary Arteries (Epicardial Coronary Artery Luminal Narrowing <10%) Figure S1. Association of history of myocardial infarction and educational attainment dichotomized at college education with all‐cause mortality. Click here for additional data file.
  24 in total

1.  Socioeconomic position and incidence of acute myocardial infarction: a meta-analysis.

Authors:  Edison Manrique-Garcia; Anna Sidorchuk; Johan Hallqvist; Tahereh Moradi
Journal:  J Epidemiol Community Health       Date:  2010-09-14       Impact factor: 3.710

Review 2.  Effects of education and income on cardiovascular outcomes: A systematic review and meta-analysis.

Authors:  Win Khaing; Sakda A Vallibhakara; John Attia; Mark McEvoy; Ammarin Thakkinstian
Journal:  Eur J Prev Cardiol       Date:  2017-04-13       Impact factor: 7.804

3.  2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson; Harmon S Jordan; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

4.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Scott M Grundy; Neil J Stone; Alison L Bailey; Craig Beam; Kim K Birtcher; Roger S Blumenthal; Lynne T Braun; Sarah de Ferranti; Joseph Faiella-Tommasino; Daniel E Forman; Ronald Goldberg; Paul A Heidenreich; Mark A Hlatky; Daniel W Jones; Donald Lloyd-Jones; Nuria Lopez-Pajares; Chiadi E Ndumele; Carl E Orringer; Carmen A Peralta; Joseph J Saseen; Sidney C Smith; Laurence Sperling; Salim S Virani; Joseph Yeboah
Journal:  J Am Coll Cardiol       Date:  2018-11-10       Impact factor: 24.094

Review 5.  Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization.

Authors:  S Yusuf; S Reddy; S Ounpuu; S Anand
Journal:  Circulation       Date:  2001-11-27       Impact factor: 29.690

6.  Association of Educational Attainment With Lifetime Risk of Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.

Authors:  Yasuhiko Kubota; Gerardo Heiss; Richard F MacLehose; Nicholas S Roetker; Aaron R Folsom
Journal:  JAMA Intern Med       Date:  2017-08-01       Impact factor: 21.873

Review 7.  Socioeconomic status and cardiovascular disease: risks and implications for care.

Authors:  Alexander M Clark; Marie DesMeules; Wei Luo; Amanda S Duncan; Andy Wielgosz
Journal:  Nat Rev Cardiol       Date:  2009-09-22       Impact factor: 32.419

8.  Association Between Living in Food Deserts and Cardiovascular Risk.

Authors:  Heval M Kelli; Muhammad Hammadah; Hina Ahmed; Yi-An Ko; Matthew Topel; Ayman Samman-Tahhan; Mossab Awad; Keyur Patel; Kareem Mohammed; Laurence S Sperling; Priscilla Pemu; Viola Vaccarino; Tene Lewis; Herman Taylor; Greg Martin; Gary H Gibbons; Arshed A Quyyumi
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-09

9.  Quantifying the contributions of behavioral and biological risk factors to socioeconomic disparities in coronary heart disease incidence: the MORGEN study.

Authors:  Kiarri N Kershaw; Mariël Droomers; Whitney R Robinson; Mercedes R Carnethon; Martha L Daviglus; W M Monique Verschuren
Journal:  Eur J Epidemiol       Date:  2013-09-14       Impact factor: 8.082

10.  Cohort profile: the Emory Cardiovascular Biobank (EmCAB).

Authors:  Yi-An Ko; Salim Hayek; Pratik Sandesara; Ayman Samman Tahhan; Arshed Quyyumi
Journal:  BMJ Open       Date:  2017-12-29       Impact factor: 2.692

View more
  7 in total

1.  Geographic Association Between Incidence of Acute Appendicitis and Socioeconomic Status.

Authors:  Reece A Golz; David R Flum; Sabrina E Sanchez; XiaoHang Liu; Courtney Donovan; F Thurston Drake
Journal:  JAMA Surg       Date:  2020-04-01       Impact factor: 14.766

2.  Physical resilience after a diagnosis of cardiovascular disease among offspring of long-lived siblings.

Authors:  Angéline Galvin; Mary Feitosa; Konstantin Arbeev; Allison L Kuipers; Mary Wojczynski; Svetlana Ukrainsteva; Kaare Christensen
Journal:  Eur J Ageing       Date:  2021-08-17

3.  Association of road traffic noise exposure and prevalence of coronary artery disease: A cross-sectional study in North India.

Authors:  Towseef Ahmed Gilani; Mohammad Shafi Mir
Journal:  Environ Sci Pollut Res Int       Date:  2021-05-24       Impact factor: 4.223

4.  Low Educational Attainment is a Predictor of Adverse Outcomes in Patients With Coronary Artery Disease.

Authors:  Heval M Kelli; Anurag Mehta; Ayman S Tahhan; Chang Liu; Jeong Hwan Kim; Tiffany A Dong; Devinder S Dhindsa; Bahjat Ghazzal; Muaaz K Choudhary; Pratik B Sandesara; Salim S Hayek; Matthew L Topel; Ayman A Alkhoder; Mohamed A Martini; Arianna Sidoti; Yi-An Ko; Tene T Lewis; Viola Vaccarino; Laurence S Sperling; Arshed A Quyyumi
Journal:  J Am Heart Assoc       Date:  2019-09-02       Impact factor: 5.501

5.  Projected New-Onset Cardiovascular Disease by Socioeconomic Group in Australia.

Authors:  Kaitlyn Hastings; Clara Marquina; Jedidiah Morton; Dina Abushanab; Danielle Berkovic; Stella Talic; Ella Zomer; Danny Liew; Zanfina Ademi
Journal:  Pharmacoeconomics       Date:  2022-01-17       Impact factor: 4.558

6.  Non-Persistence with Medication as a Mediator for the Social Inequality in Risk of Major Adverse Cardiovascular Events in Patients with Incident Acute Coronary Syndrome: A Nationwide Cohort Study.

Authors:  Christina Boesgaard Graversen; Jan Brink Valentin; Mogens Lytken Larsen; Sam Riahi; Teresa Holmberg; Søren Paaske Johnsen
Journal:  Clin Epidemiol       Date:  2021-11-13       Impact factor: 4.790

7.  Association of Living in Urban Food Deserts with Mortality from Breast and Colorectal Cancer.

Authors:  Abigail J Fong; Kelly Lafaro; Philip H G Ituarte; Yuman Fong
Journal:  Ann Surg Oncol       Date:  2020-08-25       Impact factor: 5.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.